ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research

News   Apr 16, 2012

 
ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research
 
 
 

RELATED ARTICLES

Psoriasis Drug Also Reduces Aortic Inflammation

News

An antibody used to treat the autoimmune skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.

READ MORE

Tiny Kidneys: Building Better Models to Test Drugs

News

A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

READ MORE

Could Alzheimer's Drug Repair Brain Damage After Alcohol Binges?

News

A drug used to slow cognitive decline in Alzheimer's disease could offer clues on how drugs might one day be able to reverse brain changes that affect learning and memory in teens and young adults who binge drink.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE